2-chloroadenosine has been researched along with caffeine in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (42.86) | 18.7374 |
1990's | 15 (42.86) | 18.2507 |
2000's | 4 (11.43) | 29.6817 |
2010's | 1 (2.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; van Galen, PJ; Williams, M | 1 |
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Butts-Lamb, P; Daly, JW; Padgett, W; Shamim, MT; Waters, J | 1 |
Daly, JW | 1 |
Arslan, G; Fredholm, BB; Kull, B; Lorenzen, A; Nilsson, C; Owman, C; Schwabe, U | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Bertarelli, DC; Borrmann, T; Florin, NC; Hinz, S; Li, W; Müller, CE; Scheiff, AB | 1 |
de Lera Ruiz, M; Lim, YH; Zheng, J | 1 |
Arizono, K; Brady, FO; Garrett, SH; Xiong, X | 1 |
Albertson, TE; Derlet, RW; Tseng, JC | 1 |
Farb, DH; Friedman, L; Gibbs, TT; Roca, DJ; Rozenberg, I; Schiller, GD | 1 |
Mitsumoto, Y; Mohri, T; Ohkubo, T | 1 |
Dulloo, AG; Girardier, L; Seydoux, J | 1 |
Beninger, RJ; Josselyn, SA | 1 |
Contreras, E; Germany, A; Villar, M | 1 |
Baldwin, HA; File, SE | 1 |
Holloway, WR; Thor, DH | 1 |
Cheung, WT; Lee, CM; Ng, TB | 1 |
Clark, RL; Cusick, WA; Eschbach, K; Heyse, JF | 1 |
Coffin, VL; Spealman, RD | 1 |
Ferrario, P; Mantegazza, P; Zambotti, F; Zecca, L; Zonta, N | 1 |
Mantegazza, P; Tammiso, R; Zambotti, F; Zecca, L; Zonta, N | 1 |
Lal, H; Spencer, DG | 1 |
Butts-Lamb, P; Daly, JW; Padgett, W | 1 |
Kulkarni, SK; Mehta, AK | 1 |
Barber, R; Butcher, RW; Goka, TJ | 1 |
Dragunow, M; Goddard, GV | 1 |
Breimer, DD; Danhof, M; Ijzerman, AP; Mathoôt, RA; Soudijn, W | 1 |
Behzadi, J; Mirnajafi-Zadeh, J; Pourgholami, MH | 1 |
Lobo, MG; Oliveira, DG; Ribeiro, JA; Sebastião, AM | 1 |
Mirnajafi-Zadeh, J; Palizvan, MR; Pourgholami, MH; Rostampour, M | 1 |
Cunha, RA; Gonçalves, ML; Ribeiro, JA | 1 |
Fallahi, M; Mirnajafi-Zadeh, J; Palizvan, MR; Pourgholami, MH; Rostampour, M | 1 |
Flood, AJ; Headrick, JP; Willems, L | 1 |
Klitgaard, H; Margineanu, DG | 1 |
3 review(s) available for 2-chloroadenosine and caffeine
Article | Year |
---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
Adenosine receptors: targets for future drugs.
Topics: Adenosine; Adenosine Triphosphate; Animals; Humans; Ligands; Receptors, Cell Surface; Receptors, Purinergic; Structure-Activity Relationship; Xanthines | 1982 |
Adenosine A2A receptor as a drug discovery target.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction | 2014 |
32 other study(ies) available for 2-chloroadenosine and caffeine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
Topics: Adenosine; Animals; Cerebral Cortex; In Vitro Techniques; Rats; Receptors, Cell Surface; Receptors, Purinergic; Solubility; Structure-Activity Relationship | 1985 |
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Kinetics; PC12 Cells; Phenethylamines; Polymerase Chain Reaction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Triazoles; Tritium | 1999 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
Topics: Adenosine A2 Receptor Antagonists; Animals; Drug Design; Humans; Kinetics; Ligands; Mice; Protein Binding; Radioligand Assay; Rats; Receptor, Adenosine A2B; Xanthines | 2009 |
Purinergic agonist induction of metallothionein.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Cells, Cultured; Cladribine; Deoxyadenosines; Dose-Response Relationship, Drug; Immunoblotting; Liver; Male; Metallothionein; Rats; Rats, Inbred Strains; RNA, Messenger; Theophylline; Time Factors; Transcription, Genetic; Vasodilator Agents | 1992 |
Potentiation of cocaine and d-amphetamine toxicity with caffeine.
Topics: 2-Chloroadenosine; Animals; Caffeine; Cocaine; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Synergism; Male; Pentoxifylline; Poisoning; Rats; Rats, Inbred Strains; Seizures | 1992 |
gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; Allosteric Regulation; Animals; Barbital; Barbiturates; Brain; Caffeine; Cells, Cultured; Chick Embryo; Flumazenil; Flunitrazepam; Flurazepam; gamma-Aminobutyric Acid; Kinetics; Neurons; Pentobarbital; Receptors, GABA-A; Tetrodotoxin; Theophylline; Veratridine | 1990 |
Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives.
Topics: 2-Chloroadenosine; Adenosine; Affinity Labels; Animals; Biological Transport; Caffeine; Cells, Cultured; Cytarabine; Dipyridamole; Embryo, Mammalian; Hippocampus; Kinetics; Neuroglia; Neurons; Pentoxifylline; Rats; Sodium; Theophylline; Thioinosine; Tritium; Xanthines | 1991 |
Peripheral mechanisms of thermogenesis induced by ephedrine and caffeine in brown adipose tissue.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Deaminase; Adipose Tissue, Brown; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature Regulation; Caffeine; Culture Techniques; Dose-Response Relationship, Drug; Drug Synergism; Ephedrine; Male; Oxygen Consumption; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Theophylline; Xanthines | 1991 |
Behavioral effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine.
Topics: 2-Chloroadenosine; Adenosine; Animals; Behavior, Animal; Caffeine; Corpus Striatum; Dopamine; Flupenthixol; Male; Microinjections; Rats; Rats, Inbred Strains; Rotation; Stereoisomerism; Stereotyped Behavior | 1991 |
Effects of some adenosine analogs on morphine-induced analgesia and tolerance.
Topics: 2-Chloroadenosine; Adenosine; Analgesics; Animals; Caffeine; Drug Synergism; Drug Tolerance; Injections, Intraventricular; Mice; Morphine; Naloxone; Phenylisopropyladenosine | 1990 |
Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors.
Topics: 2-Chloroadenosine; Adenosine; Alprazolam; Anxiety; Caffeine; Chlordiazepoxide; Clonidine; Flumazenil; Motor Activity; Muscle Relaxants, Central; Norepinephrine; Propranolol; Receptors, Adrenergic; Receptors, GABA-A; Receptors, Purinergic; Social Behavior | 1989 |
Interactive effects of caffeine, 2-chloroadenosine and haloperidol on activity, social investigation and play fighting of juvenile rats.
Topics: 2-Chloroadenosine; Adenosine; Aggression; Animals; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Male; Motor Activity; Rats; Receptors, Cell Surface; Receptors, Purinergic; Social Behavior | 1985 |
Potentiation of the anti-lipolytic effect of 2-chloroadenosine after chronic caffeine treatment.
Topics: 2-Chloroadenosine; Adenosine; Adipose Tissue; Animals; Body Weight; Caffeine; Cell Membrane; Drug Synergism; In Vitro Techniques; Lipolysis; Male; Organ Size; Radioligand Assay; Rats; Rats, Inbred Strains; Xanthines | 1988 |
Interactions between caffeine and adenosine agonists in producing embryo resorptions and malformations in mice.
Topics: 2-Chloroadenosine; Abnormalities, Drug-Induced; Adenosine; Animals; Body Weight; Caffeine; Drug Administration Schedule; Drug Synergism; Embryo Loss; Female; Fetal Death; Mice; Mice, Inbred Strains; Phenylisopropyladenosine; Pregnancy | 1987 |
Behavioral and cardiovascular effects of analogs of adenosine in cynomolgus monkeys.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Blood Pressure; Caffeine; Cardiovascular System; Clonidine; Cocaine; Dextroamphetamine; Heart Rate; Isomerism; Macaca fascicularis; Male; Phenylisopropyladenosine | 1987 |
Effects of 2-chloroadenosine on hippocampal GABA content and turnover.
Topics: 2-Chloroadenosine; 4-Aminobutyrate Transaminase; Adenosine; Aminooxyacetic Acid; Animals; Caffeine; gamma-Aminobutyric Acid; Hippocampus; Injections, Intraventricular; Kinetics; Male; Rats; Rats, Inbred Strains | 1986 |
Purine involvement in morphine antinociception.
Topics: 2-Chloroadenosine; Adenosine; Analgesia; Animals; Body Temperature; Bucladesine; Caffeine; Male; Morphine; Phenylisopropyladenosine; Rats; Rats, Inbred Strains | 1984 |
Discriminative stimulus properties of L-phenylisopropyl adenosine: blockade by caffeine and generalization to 2-chloroadenosine.
Topics: 2-Chloroadenosine; Adenosine; Animals; Caffeine; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Phenylisopropyladenosine; Rats; Receptors, Cell Surface; Receptors, Purinergic | 1983 |
Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.
Topics: 2-Chloroadenosine; Adenosine; Adenylyl Cyclases; Animals; Brain; Caffeine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Theobromine; Theophylline; Xanthines | 1983 |
Evidence for the presence of P1- and P2-purinoceptors in rat caecum.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Animals; Caffeine; Cecum; Cyclic AMP; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Quinidine; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Theophylline | 1983 |
Hormone and methylxanthine action on breast epithelial cells.
Topics: 2-Chloroadenosine; Adenosine; Animals; Breast; Breast Neoplasms; Caffeine; Cell Line; Cyclic AMP; Epithelium; Female; Fibrocystic Breast Disease; Humans; Mice; Terbutaline; Xanthines | 1984 |
Adenosine modulation of amygdala kindling.
Topics: 2-Chloroadenosine; Adenosine; Aminophylline; Amygdala; Animals; Caffeine; Differential Threshold; Kindling, Neurologic; Male; Papaverine; Rats; Rats, Inbred Strains; Seizures | 1984 |
Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.
Topics: 2-Chloroadenosine; Animals; Caffeine; Hemodynamics; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline | 1996 |
Effect of intraperitoneal and intrahippocampal (CA1) 2-chloroadenosine in amygdaloid kindled rats.
Topics: 2-Chloroadenosine; Amygdala; Animals; Caffeine; Central Nervous System Stimulants; Electrophysiology; Hippocampus; Injections; Injections, Intraperitoneal; Kindling, Neurologic; Male; Rats; Rats, Sprague-Dawley; Seizures | 1997 |
On the high affinity of 8-cyclohexylcaffeine for the presynaptic inhibitory adenosine receptor present in rat motor nerve terminals.
Topics: 2-Chloroadenosine; Animals; Caffeine; Electric Stimulation; Female; In Vitro Techniques; Male; Neuromuscular Junction; Presynaptic Terminals; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Xanthines | 1997 |
Intra-amygdala infusion of 2-chloroadenosine suppresses amygdala-kindled seizures.
Topics: 2-Chloroadenosine; Amygdala; Animals; Anticonvulsants; Caffeine; Central Nervous System Stimulants; Injections; Kindling, Neurologic; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Seizures; Time Factors | 1997 |
Adenosine A2A receptors facilitate 45Ca2+ uptake through class A calcium channels in rat hippocampal CA3 but not CA1 synaptosomes.
Topics: 2-Chloroadenosine; Adenosine; Animals; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Radioisotopes; Hippocampus; Male; omega-Agatoxin IVA; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Spider Venoms; Synaptosomes; Veratridine; Xanthines | 1997 |
Anticonvulsant action of 2-chloroadenosine injected focally into the perirhinal cortex in amygdaloid kindled rats.
Topics: 2-Chloroadenosine; Adenosine; Amygdala; Analysis of Variance; Animals; Anticonvulsants; Caffeine; Dose-Response Relationship, Drug; Injections; Kindling, Neurologic; Male; Olfactory Pathways; Rats; Rats, Sprague-Dawley; Reaction Time; Seizures | 1999 |
Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart.
Topics: 2-Chloroadenosine; Adenosine; Adenosine Diphosphate; Animals; Caffeine; Coronary Circulation; Heart; Male; Mice; Mice, Inbred C57BL; Models, Animal; Myocardial Contraction; Myocardial Reperfusion Injury; Nitroprusside; Perfusion; Phenethylamines; Purinergic P1 Receptor Antagonists; Vasodilator Agents; Xanthines | 2002 |
Caffeine-induced epileptiform field potentials in rat hippocampal slices: a pharmacological characterization.
Topics: 2-Chloroadenosine; Animals; Anticonvulsants; Caffeine; Calcium; Calcium Channel Blockers; Calcium Signaling; Central Nervous System Stimulants; Electrophysiology; Enzyme Inhibitors; Epilepsy; Evoked Potentials; Flunarizine; Hippocampus; In Vitro Techniques; Male; Perfusion; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Ruthenium Red; Ryanodine Receptor Calcium Release Channel; Thapsigargin | 2004 |